OR WAIT null SECS
June 29, 2021
Otsuka Pharmaceuticals Europe has filed an initial marketing authorization application to the European Medicines Agency for voclosporin.
June 24, 2021
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
June 23, 2021
Centrient started production at its new statins API manufacturing unit in Toansa, India.
June 21, 2021
Exscientia has entered into a binding agreement to acquire the artificial intelligence precision-based medicines company, Allcyte.
June 16, 2021
Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.
Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.
Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.
June 11, 2021
CPI has revealed an agreement with DFE Pharma, making it the latest partner of the Medicines Manufacturing Innovation Centre (MMIC) collaboration.
Immodulon has received an indication of allowability from the European Patent Office for the claims in its patent application relating to its lead drug candidate.